Agreement with OBI Pharma - Additional Information (Detail) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Jun. 16, 2017 |
Jun. 30, 2017 |
Jun. 30, 2016 |
Jun. 30, 2017 |
Jun. 30, 2016 |
|
| Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |||||
| Revenue | $ 3,000 | $ 0 | $ 3,000 | $ 0 | |
| OBI Pharma | |||||
| Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |||||
| Nonrefundable payments received for sale of TH-3424 rights and obligations | $ 3,000 | ||||
| Revenue | $ 3,000 | ||||
| X | ||||||||||
- Definition Aggregate payments received for sale of rights and obligations related TH-3424. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of revenue earned from products sold or services provided under the terms of a contract, including, but not limited to, government contracts and construction contracts, classified as other. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|